NOTCH1二聚体信号对T细胞白血病发生和白血病维持至关重要
研究利用人T-ALL合成模型发现,NOTCH1二聚体信号对脐带血人造血干/祖细胞(HSPC)的白血病发生至关重要;鉴定出包括HES4在内的Notch二聚化依赖基因特征,HES4通过Δ133p53和BCL2L1/BCL-XL发挥抗凋亡作用,原代T-ALL中该特征与不良临床结局标志物直接相关。
要点
- NOTCH1二聚体信号是脐带血人HSPC发生T-ALL所必需的。
- HES4为Notch二聚化依赖基因,可诱导Δ133p53并上调BCL2L1/BCL-XL。
- 原代T-ALL中Notch二聚化依赖基因特征与不良临床结局标志物直接相关。
核心结论
- NOTCH1二聚体信号在人T细胞白血病发生和T-ALL维持中起关键作用。
- 作者认为靶向NOTCH1二聚体信号或其下游效应因子可能带来治疗获益。
研究设计与样本
- 研究使用人T-ALL合成模型、基因修饰细胞系、RNA/染色质免疫沉淀测序及原代T-ALL样本的单细胞RNA测序。
- 研究还使用了Notch二聚化依赖的患者来源T-ALL异种移植模型。
主要发现
- NOTCH1二聚体信号对脐带血人HSPC的白血病发生至关重要。
- 鉴定出Notch二聚化依赖基因特征,包括HES4转录因子,该特征在人HSPC和Notch二聚化依赖的患者来源T-ALL异种移植中赋予增殖优势。
- 在人T-ALL细胞中,HES4强制表达Δ133p53异构体,同时阻断促凋亡p53靶基因并诱导BCL2L1基因表达和抗凋亡BCL-XL蛋白。
- 原代T-ALL样本中存在具有Notch二聚化依赖基因特征的细胞亚群,该特征与促凋亡基因间接相关,并与不良临床结局细胞标志物直接相关。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy that is characterized by an expansion of T-cell progenitors and DNA mutations that lead to overactive NOTCH1 signaling in >50% of T-ALL cases. Using synthetic models of human T-ALL, we report that NOTCH1 dimeric signaling was crucial for the leukemogenesis of human hematopoietic stem/progenitor cells (HSPCs) from cord blood. We also identified a Notch dimerization-dependent gene signature, including the HES4 transcription factor, which induced a proliferative advantage in human HSPCs and in Notch dimerization-dependent, patient-derived xenografts of T-ALL. Interestingly, in human T-ALL cells, HES4 enforced the expression of the Δ133p53 isoform with the concomitant block of proapoptotic p53 target genes and the induction of BCL2L1 gene expression and antiapoptotic B-cell lymphoma extra-large protein. In addition, through an integrated experimental approach that included genetically modified cell lines, RNA/chromatin immunoprecipitation sequencing, and single-cell RNA sequencing profiles of primary T-ALL samples, we revealed cell subsets with Notch dimerization-dependent gene signatures, which indirectly correlated with proapoptotic genes and directly associated with cell markers of poor clinical outcome in primary T-ALL samples. Taken together, these findings highlight the crucial role of NOTCH1 dimeric signaling in human T-cell leukemogenesis and T-ALL maintenance, suggesting that a possible benefit can be obtained with a therapeutic strategy that target NOTCH1 dimer signaling or its downstream effectors.
引用
- Tamiro F, Padovano C, De Santis E, et al. NOTCH1 dimeric signaling is essential for T-cell leukemogenesis and leukemia maintenance. Blood. 2025. PMID: 40009499. doi:10.1182/blood.2024027020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。